Management of hyperlipidemias.
D000085:Acetates / Q000627:therapeutic use; D001835:Body Weight; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000178:diet therapy / Q000188:drug therapy; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D008074:Lipoproteins / Q000097:blood* / Q000145:classification; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009355:Neomycin / Q000627:therapeutic use; D009640:Norethindrone / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use
D000085:Acetates; D002914:Chylomicrons; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D013431:Sulfates; D003918:Dextrothyroxine; D012964:Sodium; D002994:Clofibrate; D009355:Neomycin; D009640:Norethindrone